Human liver is innervated by a dense network of extrinsic and intrinsic nerves that regulate liver regeneration. Cholangiocyte differentiation and biliary remodeling are critical for the maintenance of biliary mass, and the functional recovery during the pathogenesis of cholestatic liver diseases such as primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). With regard to the plasticity of intrahepatic cholangiocytes, it has been postulated that terminally differentiated cells of one lineage may directly differentiae into another lineage or undergo trans-differentiation. Therefore, specific subpopulations of cells, such as small cholangiocytes that express known biliary progenitor cell markers, can be hypothesized to contain a multipotent cell population that may be activated when exposed to certain pathological conditions. We have previously demonstrated a direct role for the parasympathetic and sympathetic innervation in the regulation of biliary mass and cholangiocyte functional activity. Although sensory innervation is present in the liver as dense neural networks in the fibromuscular layer of the biliary epithelium, little information exists regarding its role n the regulation of biliary proliferation and function in normal and diseased states. Our preliminary studies have indicated that small cholangiocytes possess functional pluripotent characteristics under conditions that large more senescent cholangiocytes are damaged or lost. During the damage of large cholangoicytes, this pluripotent cell population is activated by the sensory neuropeptides to repopulate damaged bile ducts and livers. Based on these compelling data, we propose the central hypothesis that small murine cholangiocytes contribute to the recovery of biliary injury through acquiring the sensory neuropeptides regulated phenotypes of large cholangiocytes under diseased conditions. The central hypothesis will be evaluated by the following three specific aims: (1) substance P (SP)-dependent sensory innervation involved in the regulation of tissue repair-related cellular functions in small and large cholangoicytes will b identified, (2) the functional role of SP- dependent miRNAs involved in differentiation-related cellular functions in biliary committed progenitors will be defined, (3) the effects of SP-associated mRNAs and miRNAs on accelerating the morphologic and functional recovery of biliary damage during chronic cholestatic liver injury in vivo. Therefore, a systematic evaluation of substance P-regulated pluripotent genes and microRNAs as markers in small cholangiocytes with the therapeutic potentials for cholestatic liver injury is proposed in this application. In addition, the translational role of the selective manipulation of gene/miRNA on biliary cell differentiation will be evaluated. The completion of the proposed studies may lead to alternative therapeutic strategies for human biliary injury. Novel insights into the mechanisms of sensory neuropeptides regulate heterogeneity in human biliary tree will be obtained. This newly acquired fundamental knowledge about regulation of differentiation by sensory neuropeptide-regulated mRNAs and miRNAs in biliary progenitors will advance the general field of cholangiocyte biology.

Public Health Relevance

Cholangiocytes have extensive potential for the reconstruction of the liver that is regulated by neuroendocrine factor substance P and the health relatedness of this grant proposal is that effective treatments are lacking for chronic cholestatic liver diseases, such as primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC). Chronic cholestatic liver diseases cause damage/growth/reconstruction of bile ducts in the liver. The rationale for our research is that the successful completion of the studies can ultimately be expected to provide a greater understanding of cholestatic liver disease progression and increase opportunities for the development of novel treatment paradigms for the maintenance of liver homeostasis during the management of chronic liver diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
4R01DK076898-07
Application #
9081580
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Burgess-Beusse, Bonnie L
Project Start
2006-12-01
Project End
2017-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
7
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Texas A&M University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
835607441
City
College Station
State
TX
Country
United States
Zip Code
77845
Sato, Keisaku; Marzioni, Marco; Meng, Fanyin et al. (2018) Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances. Hepatology :
Zhou, Tianhao; Wu, Nan; Meng, Fanyin et al. (2018) Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2-/- mice by diminishing senescence of cholangiocytes. Lab Invest 98:1449-1464
Ehrlich, Laurent; Scrushy, Marinda; Meng, Fanyin et al. (2018) Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease. Clin Res Hepatol Gastroenterol 42:296-305
Sato, Keisaku; Meng, Fanyin; Venter, Julie et al. (2018) Author Correction: The role of the secretin/secretin receptor axis in inflammatory cholangiocyte communication via extracellular vesicles. Sci Rep 8:11238
Lewis, Phillip L; Su, Jimmy; Yan, Ming et al. (2018) Complex bile duct network formation within liver decellularized extracellular matrix hydrogels. Sci Rep 8:12220
Sato, Keisaku; Meng, Fanyin; Giang, Thao et al. (2018) Mechanisms of cholangiocyte responses to injury. Biochim Biophys Acta Mol Basis Dis 1864:1262-1269
Luo, Xianjun; Li, Honggui; Ma, Linqiang et al. (2018) Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice. Gastroenterology 155:1971-1984.e4
Cai, Yuli; Li, Honggui; Liu, Mengyang et al. (2018) Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity. Hepatology 68:48-61
Kennedy, Indsey; Francis, Heather; Meng, Fanyin et al. (2017) Diagnostic and therapeutic potentials of microRNAs in cholangiopathies. Liver Res 1:34-41
Hall, Chad; Ehrlich, Laurent; Venter, Julie et al. (2017) Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth. Cancer Lett 386:179-188

Showing the most recent 10 out of 87 publications